New medications are the first to benefit from initiative that aims to speed up access to oncology breakthroughs ...

Researchers found an antibody that seems to play a role in people with better lung cancer prognoses, but turning it into a ...

Immunotherapy is offering new hope for cancers that once had grim prognoses by harnessing the body's own immune system to ...

Immunotherapy has transformed cancer care by helping the immune system recognize and destroy tumors. But new research from ...

AbbVie ABBV has been significantly expanding its presence in the oncology space. What started initially as a two-drug franchise consisting of blood cancer drugs Imbruvica and Venclexta has also ...

AbbVie ABBV has been expanding its oncology portfolio over the past few years. While the company was originally focused on two blood-cancer drugs — Imbruvica and Venclexta — it has since built a ...

The list of medications covered by the Estonian Health Insurance Fund was expanded in January, with new additions including ...